相关实验视频

Updated: Jul 12, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

perfluoroalkyl 酸与主要的人类血液蛋白质纤维素素相互作用:实验和计算研究

Aleksandra Đurđević Đelmaš¹, Tino Šeba², Nikola Gligorijević³

¹University of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.

International journal of biological macromolecules

|February 26, 2025

概括

短链透和多化基物质 (PFAS) 与人体纤维素素结合,但不会损害其功能. 这挑战了关于它们的生物积累的假设,并强调了进一步对健康影响研究的必要性.

科学领域:

环境化学环境化学
生物化学生物化学
毒理学毒理学毒理学

背景情况:

和多化基物质 (PFAS) 是广泛使用的合成化学品,具有环境和健康问题.
长链PFAS的监管导致越来越多地使用更短链的替代品,其生物积累潜力尚未得到充分了解.
纤维素素是人体血液中关键的蛋白质,参与凝固.

研究的目的:

为了研究短链 perfluoroalkyl 酸 (PFAA) 和人类纤维素原之间的结合相互作用.
评估PFAA结合对纤维素原生物活性的功能影响.
探索PFAA-纤维素原相互作用的分子机制和链长特异性.

主要方法:

结合实验技术,包括内在光,微尺度热泳和凝血测试.
利用了诸如分子对接之类的计算方法.
分析了三酸, perfluorobutanoic 酸和 perfluorooctanoic 酸与纤维素原的相互作用.

主要成果:

所有测试的PFAA都表现出对纤维素素的中等结合亲和力 (K_d在10^-4-10^-5 M范围内).
循环二重化和纤维素凝块形成试验没有显示纤维素原的功能障碍.
分子对接揭示了PFAA在纤维素原上独特的,链长特定的结合点.

结论:

短链PFAA可以与纤维素素相互作用,而不会破坏其主要凝固功能.
这些发现挑战了假设更短的PFAS链具有较低的生物积累能力的假设.
进一步的研究至关重要,以了解PFAS在人体血液中积累的长期健康影响.

关键词:

人类纤维素原体分子对接是分子对接.在PFAS中,有很多方法.

更多相关视频

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

相关概念视频

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...